Abstract:Patients with type 2 diabetes mellitus (T2DM) exhibit hyperglycemia and hyperinsulinemia and increased risk of fracture at early stage, but they were found to have normal or even enhanced bone mineral density (BMD). This study was aimed to examine the molecular mechanisms governing changes in bone structure and integrity under both hyperglycemic and hyperinsulinemic conditions. Monocytes were isolated from the bone marrow of the C57BL/6 mice, induced to differentiate into osteoclasts by receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) and exposed to high glucose (33.6 mmol/L), high insulin (1 μmol/L), or a combination of high glucose/high insulin (33.6 mmol/L glucose and 1 μmol/L insulin). Cells cultured in α-MEM alone served as control. After four days of incubation, the cells were harvested and stained for tartrate resistant acid phosphatase (TRAP). Osteoclast-related genes including RANK, cathepsin K and TRAP were determined by using real-time PCR. The resorptive activity of osteoclasts was measured by using a pit formation assay. Osteoclasts that were derived from monocytes were of multinucleated nature and positive for TRAP, a characteristic marker of osteoclasts. Cell counting showed that the number of osteoclasts was much less in high glucose and high glucose/high insulin groups than in normal glucose and high insulin groups. The expression levels of RANK and cathepsin K were significantly decreased in high glucose, high insulin and high glucose/high insulin groups as compared with normal glucose group, and the TRAP activity was substantially inhibited in high glucose environment. The pit formation assay revealed that the resorptive activity of osteoclasts was obviously decreased in high glucose group and high glucose/high insulin group as compared with normal group. It was concluded that osteoclastogenesis is suppressed under hyperglycemic and hyperinsulinemic conditions, suggesting a disruption of the bone metabolism in diabetic patients.

High Glucose Impaired Estrogen Receptor Alpha Signaling Via Β-Catenin in Osteoblastic MC3T3-E1

High Glucose Conditions Suppress the Function of Bone Marrow-Derived Endothelial Progenitor Cells Via Inhibition of the Enos-Caveolin-1 Complex.

Hyperglycemia Induces Endoplasmic Reticulum Stress-Dependent CHOP Expression in Osteoblasts

Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro

Effects of high glucose on the proliferation and differentiation of primary osteoblasts

Estrogens and Hyperglycemic Modulation of mRNAs Expressions Involved in Bone Metabolism: An Overshadowed Association?

High glucose-induced inhibition of osteoblast like MC3T3-E1 differentiation promotes mitochondrial perturbations

MiR-378 Overexpression Attenuates High Glucose-Suppressed Osteogenic Differentiation Through Targeting CASP3 and Activating PI3K/Akt Signaling Pathway.

Effect of Estradiol on High Glucose‑induced Osteoblast Injury.

Study on effects of high glucose on the activity of osteoblastic cells (MC3T3-E1)

Hyperglycemia impairs osteoblast cell migration and chemotaxis due to a decrease in mitochondrial biogenesis

Effects of glucose on proliferation and related genes expression of human osteoblast MG63

Investigation for GSK3β Expression in Diabetic Osteoporosis and Negative Osteogenic Effects of GSK3β on Bone Marrow Mesenchymal Stem Cells under a High Glucose Microenvironment.

Zoledronic acid epigenetically alleviates high-glucose-suppressed osteogenic differentiation of MC3T3-E1 cells

Different concentrations of glucose regulate proliferation and osteogenic differentiation of osteoblasts via the PI3 kinase/Akt pathway.

miRNA-seq analysis of high glucose induced osteoblasts provides insight into the mechanism underlying diabetic osteoporosis

MSI1 Stabilizes MACF1 to Inhibit Apoptosis of MC3T3-E1 Cells Induced by High Glucose and Promote Osteogenic Differentiation Through Wnt/β-Catenin Signaling Pathway

1,25(OH)2D3 inhibits the deleterious effects induced by high glucose on osteoblasts through undercarboxylated osteocalcin and insulin signaling.

Zoledronate promotes osteoblast differentiation in high-glucose conditions via the p38MAPK pathway

Variability Of High Glucose Environment Affects Proliferation And Differentiation Of Osteoblasts By Changing Endoplasmic Reticulum Stress

IGF-1R/-catenin signaling axis is implicated in streptozotocin exacerbating bone impairment in ovariectomized rats